Miracor Medical SA: Miracor Medical starts 2nd randomized st

AWANS, Belgium, March 29, 2022 /PRNewswire/ -- Miracor Medical SA (Miracor Medical) today announced the first patient enrolled in the PICSO-AMI-V study to evaluate the benefits of PiCSO (Pressure

Related Keywords

Jawans , Waals Gewest , Belgium , United Kingdom , France , Coll Cardiol , Olivier Delporte , Kostenloser Wertpapierhandel , Oxford Heart Center , University Hospital Of Toulouse , Miracor Medical , Elevation Myocardial Infarction , University Hospital , Professor Didier Carri , Professor Adrian Banning , Device Effect , Microcirculatory Resistance , Resistive Reserve Ratio , Walloon Region , Oxford Acute Myocardial Infarction , Intermittent Coronary Sinus Occlusion , Coronary Sinus Occlusion , Cardiovasc Interv , Relationship Between Infarct Size , Outcomes Following Primary , Patient Level Analysis From , Miracor , Medical , Starts , Randomized , Study , Targeting , Xpanded , Indications , Patients , Wave , Teen , Reated , Icso ,